Latest Clinical Adoption News

Page 8 of 8

Opthea Unveils Sozinibercept’s Promise to Revolutionize Wet AMD Treatment

Opthea Limited has spotlighted Sozinibercept as a potential game-changer in wet age-related macular degeneration (AMD) therapy, presenting compelling clinical data and a clear path to U.S. market entry.

Victor Sage

29 Jan 2025

Top